These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 25452198

  • 21. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M, SPYRAL HTN-OFF MED trial investigators*.
    Lancet; 2017 Nov 11; 390(10108):2160-2170. PubMed ID: 28859944
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B.
    Blood Press; 2014 Aug 11; 23(4):228-32. PubMed ID: 24432803
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. First-in-man radial access renal denervation with the ReCor Radiance™ catheter.
    Daemen J, Van Mieghem N.
    EuroIntervention; 2015 Feb 11; 10(10):1209-12. PubMed ID: 25493912
    [Abstract] [Full Text] [Related]

  • 28. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S, Dörr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F.
    J Hypertens; 2015 Dec 11; 33(12):2512-8. PubMed ID: 26485461
    [Abstract] [Full Text] [Related]

  • 29. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2013 Aug 11; 36(4):987-91. PubMed ID: 23771326
    [Abstract] [Full Text] [Related]

  • 30. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F.
    Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557
    [Abstract] [Full Text] [Related]

  • 31. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 11; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 May 11; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 36. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H, de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Gaspar A, Sousa H, Canha Gomes A, Andrade MJ, Carvalho MS, Campante Teles R, Raposo L, Mesquita Gabriel H, Pereira Machado F, Mendes M.
    Rev Port Cardiol; 2014 Apr 11; 33(4):197-204. PubMed ID: 24472425
    [Abstract] [Full Text] [Related]

  • 37. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan 11; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 38. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au.
    Hypertension; 2011 May 09; 57(5):911-7. PubMed ID: 21403086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.